Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-22

Clinical Trial Update: Effect of Artificial Sweetener (AFS) on Glucose Metabolism in Patients with Type 1 Diabetes (T1D)

View source ↗

Summary

This trial investigates the effect of the artificial sweetener AFS on glucose metabolism in people with Type 1 diabetes mellitus and in healthy subjects. It is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AFS (Artificial Sweetener) (Artificial sweetener)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Type 1 Diabetes (T1D), Healthy Subjects | Status: RECRUITING